The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Inhaled Bronchodilators Reduce Dynamic Hyperinflation During Exercise in Patients With Chronic Obstructive Pulmonary Disease
Abstract
Dynamic hyperinflation (DH) is a major pathophysiologic consequence of airflow limitation during exercise in patients with chronic obstructive pulmonary disease (COPD) and an important contributing factor to breathlessness. In this study we aimed to examine the effect of inhaled beta agonist therapy on DH during exercise in these patients and the relationship between changes in DH and breathlessness. In 13 COPD patients (mean age 65.1 +/- 2.0, FEV1 1.20 +/- 0.17, FEV1/FVC 40 +/- 3) we measured pulmonary function tests, exercise breathlessness by Borg score, and exercise flow volume and pressure volume loops on two separate days. Prior to testing, patients randomly received inhaled placebo or albuterol on the first test day and the alternative medication on the second test day. From measurements of exercise inspiratory capacity (IC), we calculated the end-expiratory and end-inspiratory lung volumes (EELV, EILV). We used esophageal pressure recordings to measure peak inspiratory esophageal pressure (Pesins) during exercise and this was related to the maximal capacity for pressure generation taking into account lung volume and airflow changes (Pcapi). Bronchodilator caused significant increase in both FEV1 and FVC (+0.23 and +0.51, p<0.01). Comparisons of breathlessness, exercise volumes, and pressures were made at the highest equivalent work load. There was a significant reduction in the peak exercise EELV/TLC (80 +/- 0.02% to 76 +/- 0.02%, p<0.05) while the peak EILV/TLC decreased by 2% (97 +/- 1% to 95 +/- 1%, p<0.05). The peak Pesins/Pcapi decreased (0.79 +/- 0.10 to 0.57 +/- 0.05, p<0.05), and the Pcapi - Pesins increased (7.4 +/- 3 to 13.0 +/- 3 cm H2O, p<0.05). There was significant improvement in neuroventilatory coupling for volume change (Pesins/Pcapi/VT/TLC 5.45 +/- 0.5 to 3.25 +/- 1.0, p<0.05). There was a significant reduction in breathlessness as measured by Borg score (4.5 +/- 0.7 to 3.1 +/- 0.5, p<0.05) and there was a significant correlation between delta Borg and delta EILV/TLC (r=0.771, p<0.01) with a trend for Pesins/Pcapi/VT/TLC (r=0.544, p=0.067). There was also a significant correlation between delta EELV/TLC and delta Pesins/Pcapi/VT/TLC (r=0.772, p<0.01). The relationships between delta Borg, delta resting volumes, and flow rates were not significant. We conclude that in patients with COPD, inhaled bronchodilator reduces exercise DH and improves inspiratory pressure reserve and neuroventilatory coupling. Changes in DH and neuroventilatory coupling were the main determinants of reduced breathlessness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, interventions that deflate the lungs (ie, reduce EILV and EELV) and delay the onset of critical VT constraints consistently reduce dyspnea intensity in patients with COPD during exercise.45,46,55,56”
From Pathogenesis of hyperinflation in chronic obstructive pulmonary disease (2014) · cites this paper as [55]
In the citing paper
“Pharmacological interventions that reduce operating lung volumes and delay the onset of ventilatory limitation consistently reduce the intensity of dyspnea during exercise in patients with COPD.46,55,56”
From Pathogenesis of hyperinflation in chronic obstructive pulmonary disease (2014) · cites this paper as [55]
Citations
Cites
Psychophysical bases of perceived exertion
BORG, G. A. V. (1982) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-198205000-00012 · Cited by 16,580
Standardization of Spirometry — 1987 Update
Buist, A. S. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.5.1073 · Cited by 3,256
O'Donnell, D. E., & Webb, K. A. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1351 · Cited by 543
The n-of-1 Randomized Controlled Trial: Clinical Usefulness
Guyatt, G., Keller, J. L., Jaeschke, R., Rosenbloom, D., Adachi, J. D., & Newhouse, M. T. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-4-293 · Cited by 320
Pulmonary mechanics during exercise in subjects with chronic airflow obstruction
Stubbing, D. G., Pengelly, L. D., Morse, J. L., & Jones, N. L. (1980) · Journal of Applied Physiology · doi:10.1152/jappl.1980.49.3.511 · Cited by 314
Potter, W. A., Ólafsson, S., & Hyatt, R. E. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106563 · Cited by 241
Murciano, D., Auclair, M.-H., Parienté, R., & Aubier, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906083202304 · Cited by 223
Chest wall mechanics during exercise in patients with severe chronic air-flow obstruction.
Dodd, D., Brancatisano, T. P., & Engel, L. A. (1984) · PubMed · doi:10.1164/arrd.1984.129.1.33 · Cited by 195
Effect of mild-to-moderate airflow limitation on exercise capacity
Babb, T. G., Viggiano, R. W., Hurley, B. F., Staats, B., & RODARTE, J. R. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.70.1.223 · Cited by 195
Dose response relation to oral theophylline in severe chronic obstructive airways disease.
Chrystyn, H., Mulley, B. A., & Peake, M. D. (1988) · BMJ · doi:10.1136/bmj.297.6662.1506 · Cited by 164
Cited by
Sorted by citations
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,405
ATS/ACCP statement on cardiopulmonary exercise testing
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.2.211 · Cited by 3,026
ATS/ACCP statement on cardiopulmonary exercise testing.
Ross, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.167.10.950 · Cited by 2,563
American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation
Nici, L., Donner, C., Wouters, E., Zuwallack, R., Ambrosino, N., Bourbeau, J., Carone, M., Celli, B., Engelen, M., Fahy, B., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1211st · Cited by 1,966
Dynamic Hyperinflation and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
O'DONNELL, D. E., REVILL, S. M., & WEBB, K. A. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.5.2012122 · Cited by 1,076
Dyspnea: Mechanisms, Assessment, and Management: A Consensus Statement
(1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.ats898 · Cited by 1,052
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Casaburi, R. H., Mahler, D. A., Jones, P., Wanner, A., Pedro, G. S. S., ZuWallack, R., Menjoge, S., Serby, C. W., & Witek, T. J. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00269802 · Cited by 881
Dyspnea Mechanisms, Assessment and Management: A Consensus Statement
Editorial, A. (2005) · PULMONOLOGIYA · doi:10.18093/0869-0189-2005-0-2-9-36 · Cited by 859
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
O'Donnell, D. E., Flüge, T., Gerken, F., Hamilton, A., Webb, K., Aguilaniu, B., Make, B., & Magnussen, H. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00116004 · Cited by 859
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
Vincken, W., van Noord, J. A., Greefhorst, A. P. M., Bantje, T. A., Kesten, S., Korducki, L., & Cornelissen, P. J. G. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00238702 · Cited by 728
Management of Chronic Obstructive Pulmonary Disease
Sutherland, E. R., & Cherniack, R. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030415 · Cited by 569
Health status measurement in chronic obstructive pulmonary disease
Jones, P. (2001) · Thorax · doi:10.1136/thorax.56.11.880 · Cited by 547
Efficacy of Salmeterol Xinafoate in the Treatment of COPD
Mahler, D. A., Donohue, J. F., Barbee, R. A., Goldman, M. D., Gross, N. J., Wisniewski, M., Yancey, S. W., Zakes, B. A., RICKARD, K. A., & Anderson, W. H. (1999) · CHEST Journal · doi:10.1378/chest.115.4.957 · Cited by 508
Mahler, D., Wire, P., Horstman, D., Chang, C.-N., Yates, J. C., Fischer, T. L., & Shah, T. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112055 · Cited by 488
Brusasco, V. (2005) · Thorax · doi:10.1136/thx.2005.brusascolett · Cited by 431
Brusasco, V. (2003) · Thorax · doi:10.1136/thorax.58.5.399 · Cited by 408
Marin, J., Carrizo, S., Gascón, M., Sánchez, A. M., Gallego, B., & Celli, B. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.6.2003172 · Cited by 420
O'DONNELL, D. E., LAM, M., & WEBB, K. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9804004 · Cited by 532
McKenzie, D. K., & Frith, P. A. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05213.x · Cited by 368
O'Donnell, D. E., Voduc, N., Fitzpatrick, M., & Webb, K. A. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00072703 · Cited by 365
Emerging Concepts in the Evaluation of Ventilatory Limitation During Exercise
Johnson, B. D., Weisman, I. M., Zeballos, R. J., & Beck, K. C. (1999) · CHEST Journal · doi:10.1378/chest.116.2.488 · Cited by 363
Ko, F., Chan, K. P., Hui, D., Goddard, J., Shaw, J., Reid, D., & Yang, I. (2016) · Respirology (Carlton South. Print) · doi:10.1111/resp.12780 · Cited by 327
O'DONNELL, D. E., LAM, M., & WEBB, K. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9901038 · Cited by 485
Decramer, M., Rennard, S. I., Troosters, T., Mapel, D. W., Giardino, N. D., Mannino, D. M., Wouters, E. F. �., Sethi, S., & Cooper, C. B. (2008) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550802237531 · Cited by 296
Celli, B., Zuwallack, R., Wang, S., & Kesten, S. (2003) · Chest · doi:10.1378/chest.124.5.1743 · Cited by 321
Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology
Calverley, P. M. A., & Koulouris, N. G. (2005) · European Respiratory Journal · doi:10.1183/09031936.04.00113204 · Cited by 258
Respiratory mechanics during exercise in endurance‐trained men and women
Guenette, J. A., Witt, J. D., McKenzie, D. C., Road, J. D., & Sheel, A. W. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.126466 · Cited by 247
Outcomes and markers in the assessment of chronic obstructive pulmonary disease
Jones, P., & Agustí, A. G. N. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00145104 · Cited by 248
Cooper, C. B. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.08.004 · Cited by 242
Effect of Bronchoscopic Lung Volume Reduction on Dynamic Hyperinflation and Exercise in Emphysema
Hopkinson, N. S., Toma, T., Hansell, D. M., Goldstraw, P. G., Moxham, J., Geddes, D. M., & Polkey, M. I. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-961oc · Cited by 242
Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD
O’Donnell, D. E., Hamilton, A. L., & Webb, K. A. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01470.2005 · Cited by 242
The 6-Min Walk Distance, Peak Oxygen Uptake, and Mortality in COPD
Côté, C., Pinto-Plata, V., Kasprzyk, K., Dordelly, L. J., & Celli, B. R. (2007) · CHEST Journal · doi:10.1378/chest.07-2050 · Cited by 240
Mechanisms of activity-related dyspnea in pulmonary diseases
O’Donnell, D. E., Ora, J., Webb, K. A., Laveneziana, P., & Jensen, D. (2009) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2009.01.010 · Cited by 235
Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD.
O'Donnell, D., Sciurba, F., Celli, B., Mahler, D., Webb, K., Kalberg, C., & Knobil, K. (2006) · Chest · doi:10.1378/chest.130.3.647 · Cited by 249
Newton, M., O'Donnell, D., & Forkert, L. (2002) · Chest · doi:10.1378/chest.121.4.1042 · Cited by 256
Maltais, F., Hamilton, A., Marciniuk, D., Hernandez, P., Sciurba, F. C., Richter, K., Kesten, S., & O’Donnell, D. (2005) · Chest · doi:10.1378/chest.128.3.1168 · Cited by 305
The major limitation to exercise performance in COPD is dynamic hyperinflation
O'Donnell, D. E., & Webb, K. A. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90336.2008b · Cited by 221
Dyspnea and Activity Limitation in COPD: Mechanical Factors
O'Donnell, D. E., & Laveneziana, P. (2007) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550701480455 · Cited by 220
Levy, M., Quanjer, P., Booker, R., Cooper, B., Holmes, S., & Small, I. (2009) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2009.00054 · Cited by 235
Inspiratory Capacity during Exercise: Measurement, Analysis, and Interpretation
Guenette, J. A., Chin, R. C., Cory, J. M., Webb, K. A., & O'Donnell, D. E. (2013) · Pulmonary Medicine · doi:10.1155/2013/956081 · Cited by 203
Yan, S., Kamiński, D., & Śliwiński, P. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.1.9608113 · Cited by 198
The Clinical Importance of Dynamic Lung Hyperinflation in COPD
O'Donnell, D. E., & Laveneziana, P. (2006) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550600977478 · Cited by 197
Pathogenesis of hyperinflation in chronic obstructive pulmonary disease
Saey, Gagnon, P., Guenette, J., Langer, D., Laviolette, L., Mainguy, V., Maltais, F., & Ribeiro, F. (2014) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s38934 · Cited by 180
“Management and treatment of hyperinflation Bronchodilator therapy Pharmacological interventions that reduce operating lung volumes and delay the onset of ventilatory limitation consistently reduce the intensity of dyspnea during exercise in patients with COPD.(46,55,56) It should be noted, however, that the rates of i…”
Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial
D’Urzo, A. D., Ferguson, G. T., van Noord, J. A., Hirata, K., Martin, C., Horton, R., Lu, Y., Banerji, D. D., & Overend, T. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-156 · Cited by 172
Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD?
Guenette, J. A., Webb, K. A., & O’Donnell, D. E. (2012) · European Respiratory Journal · doi:10.1183/09031936.00157711 · Cited by 162
Aalbers, R., Ayres, J. G., Backer, V., Decramer, M., Lier, P. A., Magyar, P., Małolepszy, J., Ruffin, R. E., & Sybrecht, G. W. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00240902 · Cited by 153
Ventilatory limitations in chronic obstructive pulmonary disease
O???DONNELL, D. E. (2001) · Medicine and Science in Sports and Exercise · doi:10.1097/00005768-200107001-00002 · Cited by 148
Stoodley, R. G., Aaron, S. D., & Dales, R. (1999) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(99)70266-0 · Cited by 141
Pulmonary hyperinflation a clinical overview
Gibson, G. J. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09122640 · Cited by 138
Controlled breathing and dyspnea in patients with chronic obstructive pulmonary disease (COPD)
Gosselink, R. (2003) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2003.10.0025 · Cited by 138
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
Field, S. K. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s7667 · Cited by 139
Chronic Obstructive Pulmonary Disease
O’Donnell, D. E., Laveneziana, P., Webb, K. A., & Neder, J. A. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.09.008 · Cited by 140
Evaluation of bronchodilator responses in patients with “irreversible” emphysema
O'Donnell, D., Forkert, L., & Webb, K. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00216501 · Cited by 142
Update on the Management of COPD
Celli, B. R. (2008) · CHEST Journal · doi:10.1378/chest.07-2061 · Cited by 133
Peters, M. M. (2006) · Thorax · doi:10.1136/thx.2005.053470 · Cited by 128
Vogiatzis, I. (2005) · Thorax · doi:10.1136/thx.2004.039115 · Cited by 121
Taube, C., Lehnigk, B., Paasch, K., Kirsten, D., Jörres, R., & Magnussen, H. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.1.9909054 · Cited by 134
Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful?
O'Donnell, D. (2000) · Chest · doi:10.1378/chest.117.2_suppl.42s · Cited by 128
Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD
Marco, F. D., Milic‐Emili, J., Boveri, B., Carlucci, P., Santus, P., Casanova, F. M., Cazzola, M., & Centanni, S. (2002) · European Respiratory Journal · doi:10.1183/09031936.03.00020102 · Cited by 114
Iandelli, I., Aliverti, A., Kayser, B., Dellaca', R., Cala, S. J., Duranti, R., Kelly, S., Scano, G., Śliwiński, P., Yan, S., et al. (2002) · Journal of applied physiology · doi:10.1152/japplphysiol.00393.2000 · Cited by 122
Oral theophylline for chronic obstructive pulmonary disease
Ram, F. S., Jones, P., Jardim, J. R., Castro, A. A., Atallah, Á. N., Lacasse, Y., Goldstein, R. S., & Cendon, S. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003902 · Cited by 112
Exercise Capacity Deterioration in Patients With COPD
Oga, T., Nishimura, K., Tsukino, M., Satô, S., Hajiro, T., & Mishima, M. (2005) · CHEST Journal · doi:10.1378/chest.128.1.62 · Cited by 110
Inspiratory fraction and exercise impairment in COPD patients GOLD stages II–III
de Albuquerque, A. L. P., Nery, L. E., Villaça, D. S., Machado, T. Y. S., Oliveira, C. C., Paes, Â. T., & Neder, J. A. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00040506 · Cited by 104
Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD
Man, W.-D.-C., Mustfa, N., Nikoletou, D., Kaul, S., Hart, N., Rafferty, G., Donaldson, N., Polkey, M., & Moxham, J. (2004) · Thorax · doi:10.1136/thx.2003.019620 · Cited by 116
Boni, E. (2002) · Thorax · doi:10.1136/thorax.57.6.528 · Cited by 102
Chronic obstructive pulmonary disease
Vijayan, V. K. (2019) · Dental Abstracts · doi:10.1016/j.denabs.2018.11.040 · Cited by 102
Maltais, F., Celli, B., Casaburi, R., Porszasz, J., Jarreta, D., Seoane, B., & Caracta, C. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2010.11.019 · Cited by 101
Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing
O’Donnell, D. E., Elbehairy, A. F., Faisal, A., Webb, K. A., Neder, J. A., & Mahler, D. A. (2016) · European Respiratory Review · doi:10.1183/16000617.0054-2016 · Cited by 102
Use of Inhaled Anticholinergic Agents in Obstructive Airway Disease
Restrepo, R. D. (2007) · Respiratory care · doi:10.4187/respcare.07520833 · Cited by 89
Weisman, I., & Zeballos, R. (2001) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70060-5 · Cited by 22
Breathing techniques in patients with chronic obstructive pulmonary disease (COPD)
Gosselink, R. (2004) · Chronic Respiratory Disease · doi:10.1191/1479972304cd020rs · Cited by 134
Verkindre, C., Bart, F., Aguilaniu, B., Fortin, F., Guérin, J., Merre, C. L., Iacono, P., & Huchon, G. (2006) · Respiration · doi:10.1159/000089655 · Cited by 96
Disease Management of COPD With Pulmonary Rehabilitation
Tiep, B. L. (1997) · CHEST Journal · doi:10.1378/chest.112.6.1630 · Cited by 92
O’Donnell, D. E., Aaron, S. D., Bourbeau, J., Hernandez, P., Marciniuk, D. D., Balter, M. S., Ford, G. T., Gervais, A., Goldstein, R. S., Hodder, R., et al. (2004) · Canadian Respiratory Journal · doi:10.1155/2004/946769 · Cited by 92
Baarends, E. M., Schols, A. M. W. J., Westerterp, K. R., & Wouters, E. F. �. (1997) · Thorax · doi:10.1136/thx.52.9.780 · Cited by 92
Airflow obstruction and exercise
Cooper, C. B. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.10.026 · Cited by 97
Simplified detection of dynamic hyperinflation.
Gelb, A., Gutierrez, C., Weisman, I., Newsom, R., Taylor, C., & Zamel, N. (2004) · Chest · doi:10.1378/chest.126.6.1855 · Cited by 99
Impact of Chronic Obstructive Pulmonary Disease on Quality of Life: The Role of Dyspnea
Ries, A. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.08.003 · Cited by 87
Arm Exercise and Hyperinflation in Patients With COPD
Gigliotti, F., Coli, C., Bianchi, R., Grazzini, M., Stendardi, L., Castellani, C., & Scano, G. (2005) · CHEST Journal · doi:10.1378/chest.128.3.1225 · Cited by 84
Physiologic Similarities and Differences Between COPD and Asthma
Sciurba, F. C. (2004) · CHEST Journal · doi:10.1016/s0012-3692(15)31481-1 · Cited by 79
Langer, D., Ciavaglia, C. E., Neder, J. A., Webb, K. A., & O’Donnell, D. E. (2014) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.949676 · Cited by 85
Appleton, S., Jones, T., Poole, P., Lasserson, T., Adams, R. J., Smith, B. J., & Muhammed, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006101 · Cited by 75
Decreased mechanical efficiency in clinically stable patients with COPD
Baarends, E. M., Schols, A. M. W. J., Akkermans, M. A., & Wouters, E. F. �. (1997) · Thorax · doi:10.1136/thx.52.11.981 · Cited by 80
Aspects on pathophysiological mechanisms in COPD
Larsson, K. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01837.x · Cited by 83
Wouters, E. F. �. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16984-5 · Cited by 80
Kirby, M., Mathew, L., Heydarian, M., Etemad‐Rezai, R., McCormack, D. G., & Párraga, G. (2011) · Radiology · doi:10.1148/radiol.11110403 · Cited by 81
End of life care in chronic obstructive pulmonary disease: in search of a good death
Booth, S. (2008) · International Journal of COPD · doi:10.2147/copd.s698 · Cited by 78
Pharmacological treatment of chronic obstructive pulmonary disease
Montuschi, P. (2006) · International Journal of COPD · doi:10.2147/copd.2006.1.4.409 · Cited by 80
Asthma and Chronic Obstructive Pulmonary Disease Exhibit Common Origins in Any Country!
Kraft, M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2604007 · Cited by 78
Monitoring mast cell activation by prostaglandin D2 in vivo
Dahlen, S.-E. (2004) · Thorax · doi:10.1136/thx.2004.026641 · Cited by 77
Hadcroft, J., & Calverley, P. M. A. (2001) · Thorax · doi:10.1136/thorax.56.9.713 · Cited by 76
Ram, F. S., Jardin, J. R., Atallah, Á. N., Castro, A. A., Mazzini, R., Goldstein, R. S., Lacasse, Y., & Cendon, S. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2004.10.009 · Cited by 75
Hyperinflation and its management in COPD
Puente‐Maestu, L., & Stringer, W. W. (2006) · International Journal of COPD · doi:10.2147/copd.2006.1.4.381 · Cited by 74
Dyspnoea in Health and Obstructive Pulmonary Disease
MCCONNELL, A. K., & Romer, L. M. (2004) · Sports Medicine · doi:10.2165/00007256-200434020-00005 · Cited by 70
Repeatability of inspiratory capacity during incremental exercise in patients with severe COPD.
Dolmage, T., & Goldstein, R. (2002) · Chest · doi:10.1378/chest.121.3.708 · Cited by 76
Costes, F., Agresti, A., Court‐Fortune, I., Roche, F., Vergnon, J., & Barthélemy, J. (2003) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200307000-00008 · Cited by 70
Understanding dyspnoea by its language: Fig. 1—
Scano, G., Stendardi, L., & Grazzini, M. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00059404 · Cited by 93
Targeted treatment in COPD: a multi-system approach for a multi-system disease
Anderson, D. R. (2009) · International Journal of COPD · doi:10.2147/copd.s2999 · Cited by 67
Giembycz, M. A. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02640.x · Cited by 68
Metadata
- Authors
- Belman, M. J., Botnick, W. C., & Shin, J. W.
- Affiliations
- Cedars-Sinai Medical Center (US)
- ORCID
- Shin, J W
- Venue
- American journal of respiratory and critical care medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-03-01
- Volume
- 153
- Issue
- 3
- Pages
- 967-975
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2007810665
- Cited by
- 402
- References
- 21
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 1 · 2021: 1 · 2020: 8 · 2019: 5 · 2018: 1 · 2017: 4 · 2016: 9 · 2015: 6 · 2014: 8 · 2013: 10 · 2012: 10
- FWCI
- 11.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- dynamic hyperinflation, chronic obstructive pulmonary disease, inhaled beta-agonists, salbutamol, esophageal pressure, end-expiratory lung volume, inspiratory capacity, pressure-volume loops, inspiratory muscle strength, inspiratory muscle endurance, inspiratory muscle training
- MeSH terms
- Administration, Inhalation, Adrenergic beta-Agonists, Aged, Albuterol, Bronchodilator Agents, Dyspnea, Esophagus, Physical Exertion, Female, Forced Expiratory Volume, Humans, Inspiratory Capacity, Lung, Lung Diseases, Obstructive, Male, Middle Aged, Peak Expiratory Flow Rate, Pressure, Pulmonary Ventilation, Total Lung Capacity, Vital Capacity, Respiratory Mechanics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review